A type of magnetic resonance imaging called diffusion weighted imaging (DWI) will be tested to define cancerous from non-cancerous lesions in the breast.
For this study, the investigators plan to evaluate DWI scans performed in women with breast lesions identified by conventional breast MRI. The investigators will determine whether an ADC threshold can be defined for distinguishing benign and malignant lesions on DWI, assess the difference in ADC cutoffs for mass and non-mass lesions, and investigate the potential improvement in accuracy using techniques such as nonzero minimum b-value (to remove perfusion effects in the ADC measures) and normalized ADC measures (to account for variations in water content and other factors).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
100
DCE-MRI defined lesion(s) compared with biopsy results or 1-year follow up
University of Washington
Seattle, Washington, United States
Apparent Diffusion Coefficient (ADC)
Whether the Apparent Diffusion Coefficient (ADC), when used systematically in conjunction with conventional Dynamic Contrast Enhanced-Magnetic Resonance Imaging (DCE-MRI), can reduce the biopsy rate by at least 20% while maintaining sensitivity.
Time frame: 1 year
Optimal ADC Cutoffs by Lesion Type
Whether optimal ADC cutoffs are different for mass and non-mass lesion types;
Time frame: 1 year
Local and Central Review Comparison (ADC Value Differences)
Whether site-generated ADC values differ significantly from those obtained by central review;
Time frame: 1 year
Minimum B-Value for Differentiating Lesions
Whether the use of a nonzero minimum b-value to reduce perfusion effects in ADC calculation can increase the area under the curve (AUC) for differentiating benign and malignant lesions;
Time frame: 1 year
ADC Measurements/Ratios to Define Subject Lesion Variations
Whether the use of a normalized ADC measure (tumor/normal ratio) to account for inter- and intra-subject variations in water content and other factors can increase the AUC for differentiating benign and malignant lesions;
Time frame: 1 year
Combination Variables (ADC Nonzero Minimum B-Value and/or Normalized ADC)
Whether ADC with nonzero minimum b-value and/or normalized ADC can reduce the biopsy rate while maintaining sensitivity.
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.